Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lloyd

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosidesR F Schinazi, R M Lloyd, M H Nguyen, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 22, 2002
The structure of S100A12 in a hexameric form and its proposed role in receptor signallingO V Moroz, A A Antson, E J Dodson, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasmaD W Haas, L A Clough, B W Johnson, et al.
Journal of Clinical Microbiology|March 27, 2009
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testingR M Lloyd, D A Burns, J T Huong, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineR F Schinazi, A McMillan, D Cannon, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosidesR F Schinazi, R M Lloyd, M H Nguyen, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 22, 2002
The structure of S100A12 in a hexameric form and its proposed role in receptor signallingO V Moroz, A A Antson, E J Dodson, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasmaD W Haas, L A Clough, B W Johnson, et al.
Journal of Clinical Microbiology|March 27, 2009
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testingR M Lloyd, D A Burns, J T Huong, et al.
Pageof 2